Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rosko AE"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Most multiple myeloma patients have low testosterone.
    Autorzy:
    John S; a College of Medicine , The Ohio State University , Columbus , OH , USA.
    Sharma N; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Sborov DW; c Division of Hematology & Hematologic Malignancies, Department of Internal Medicine , Huntsman Cancer Institute University of Utah , Salt Lake City , UT , USA.
    Williams N; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Jones D; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Benson DM; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Efebera YA; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Rosko AE; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Vincent J; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Hofmeister CC; b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.
    Pokaż więcej
    Źródło:
    Leukemia & lymphoma [Leuk Lymphoma] 2019 Mar; Vol. 60 (3), pp. 836-838. Date of Electronic Publication: 2018 Oct 02.
    Typ publikacji:
    Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Multiple Myeloma/*blood
    Testosterone/*blood
    Biomarkers ; Diagnosis, Differential ; Female ; Humans ; Male ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Prognosis
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant.
    Autorzy:
    Cho YK; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Irby DJ; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Li J; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Sborov DW; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
    Mould DR; Projections Research Inc., Phoenixville, Pennsylvania, USA.
    Badawi M; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Dauki A; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Lamprecht M; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
    Rosko AE; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA.; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
    Fernandez S; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Center for Biostatistics, Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
    Hade EM; Center for Biostatistics, Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
    Hofmeister CC; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA.; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
    Poi M; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.; Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
    Phelps MA; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
    Pokaż więcej
    Źródło:
    CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2018 Nov; Vol. 7 (11), pp. 748-758. Date of Electronic Publication: 2018 Oct 20.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hematopoietic Stem Cell Transplantation*
    Antineoplastic Agents, Alkylating/*administration & dosage
    Melphalan/*administration & dosage
    Multiple Myeloma/*drug therapy
    Neutropenia/*chemically induced
    Antineoplastic Agents, Alkylating/adverse effects ; Antineoplastic Agents, Alkylating/pharmacokinetics ; Antineoplastic Agents, Alkylating/pharmacology ; Area Under Curve ; Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Half-Life ; Humans ; Male ; Melphalan/adverse effects ; Melphalan/pharmacokinetics ; Melphalan/pharmacology ; Middle Aged ; Models, Biological ; Neutropenia/therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incidence and survival of hematological cancers among adults ages ≥75 years.
    Autorzy:
    Krok-Schoen JL; Division of Medical Dietetics and Health Sciences, School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, Columbus, Ohio.; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
    Fisher JL; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.
    Stephens JA; Center for Biostatistics, The Ohio State University, Columbus, Ohio.
    Mims A; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
    Ayyappan S; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
    Woyach JA; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
    Rosko AE; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2018 Jul; Vol. 7 (7), pp. 3425-3433. Date of Electronic Publication: 2018 Apr 13.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies